Tracking migraine relief after a minimally invasive artery procedure
Part of Brain & nervous system, Pain clinical trials.
This study follows adults who undergo a procedure called middle meningeal artery embolization—a minimally invasive treatment that blocks blood flow to a specific artery thought to trigger migraines. The trial simply tracks your symptoms and quality of life before and after the procedure to understand how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old
- You have been diagnosed with migraine
- You have already had or plan to have middle meningeal artery embolization (a minimally invasive procedure to treat migraine)
- You can read and understand English well enough to complete surveys and consent forms
- You are able and willing to give informed consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment that places small coils in an artery behind the ear to reduce migraine days. It might be an option if you have tried at least two preventive medications without success.
This trial tests a minimally invasive procedure that blocks a blood vessel in the brain to reduce migraine attacks. It may help people who have frequent migraines and haven't found relief with standard migraine medications.
This study tests a procedure called MMA embolization (blocking a small artery in the head) to see if it can reduce migraine attacks in people with chronic, hard-to-treat migraines.
This trial tests a procedure called bilateral middle meningeal artery embolization to see if it reduces chronic migraine symptoms in people who haven't found relief from other treatments. It's for those with frequent, disabling migraines that affect both sides of the head.
This study tests a procedure called 'middle meningeal artery embolization' using a special glue-like material (SQUID) to treat chronic migraine that hasn't responded to other treatments. The goal is to see if blocking blood flow to the membrane around the brain can reduce migraine attacks.
This trial tests whether giving a numbing medicine (lidocaine) into a small artery in the face (the external carotid artery) can help people with hard-to-treat chronic migraines or persistent face/skull pain. It is for those who haven't found relief from standard treatments.
Hear when a new Migraine Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.